Li, J., Cao, S., Xu, J., & Zhong, H. (2019). De novo MET amplification promotes intrinsic resistance to first-generation EGFR tyrosine kinase inhibitors. Cancer Biol Ther.
Styl cytowania ChicagoLi, Jing-Wen, Shu-Hui Cao, Jian-Lin Xu, i Hua Zhong. "De Novo MET Amplification Promotes Intrinsic Resistance to First-generation EGFR Tyrosine Kinase Inhibitors." Cancer Biol Ther 2019.
Styl cytowania MLALi, Jing-Wen, Shu-Hui Cao, Jian-Lin Xu, i Hua Zhong. "De Novo MET Amplification Promotes Intrinsic Resistance to First-generation EGFR Tyrosine Kinase Inhibitors." Cancer Biol Ther 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..